BBI
AMGN icon

Baxter Bros Inc’s Amgen AMGN Stock Holding History

Baxter Bros Inc’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$732K Hold
2,081
– – 0.09% 101
2025
Q4 		$681K Sell
2,081
-115
-5% -$36.5K 0.08% 102
2025
Q3 		$620K Sell
2,196
-100
-4% -$29K 0.07% 104
2025
Q2 		$641K Sell
2,296
-200
-8% -$56.7K 0.08% 99
2025
Q1 		$778K Sell
2,496
-50
-2% -$14.8K 0.1% 89
2024
Q4 		$664K Sell
2,546
-42
-2% -$12.5K 0.09% 96
2024
Q3 		$834K Hold
2,588
– – 0.11% 86
2024
Q2 		$809K Sell
2,588
-365
-12% -$107K 0.11% 86
2024
Q1 		$840K Buy
2,953
+30
+1% +$8.78K 0.11% 85
2023
Q4 		$842K Buy
2,923
+45
+2% +$12.3K 0.12% 84
2023
Q3 		$773K Buy
2,878
+25
+0.9% +$6.24K 0.12% 85
2023
Q2 		$633K Sell
2,853
-7
-0.2% -$1.62K 0.09% 86
2023
Q1 		$691K Sell
2,860
-20
-0.7% -$4.91K 0.11% 82
2022
Q4 		$756K Sell
2,880
-38
-1% -$10.2K 0.12% 80
2022
Q3 		$658K Sell
2,918
-139
-5% -$33.7K 0.12% 84
2022
Q2 		$744K Sell
3,057
-18
-0.6% -$4.41K 0.13% 76
2022
Q1 		$744K Sell
3,075
-65
-2% -$14.9K 0.11% 81
2021
Q4 		$706K Sell
3,140
-70
-2% -$14.8K 0.1% 79
2021
Q3 		$683K Sell
3,210
-205
-6% -$47.2K 0.11% 79
2021
Q2 		$832K Sell
3,415
-89
-3% -$21.9K 0.13% 77
2021
Q1 		$872K Buy
3,504
+611
+21% +$146K 0.15% 73
2020
Q4 		$665K Buy
2,893
+76
+3% +$17.5K 0.13% 75
2020
Q3 		$716K Sell
2,817
-554
-16% -$137K 0.15% 73
2020
Q2 		$795K Sell
3,371
-216
-6% -$49.3K 0.19% 67
2020
Q1 		$727K Sell
3,587
-125
-3% -$27.3K 0.19% 71
2019
Q4 		$895K Buy
3,712
+1
+0% +$220 0.19% 72
2019
Q3 		$718K Sell
3,711
-160
-4% -$30.7K 0.16% 73
2019
Q2 		$713K Sell
3,871
-76
-2% -$13.6K 0.16% 75
2019
Q1 		$750K Sell
3,947
-39
-1% -$7.45K 0.18% 76
2018
Q4 		$776K Buy
3,986
+3
+0.1% +$585 0.21% 68
2018
Q3 		$826K Buy
3,983
+75
+2% +$14.8K 0.2% 73
2018
Q2 		$721K Buy
3,908
+361
+10% +$63.9K 0.19% 73
2018
Q1 		$605K Sell
3,547
-135
-4% -$24.8K 0.17% 81
2017
Q4 		$640K Buy
3,682
+203
+6% +$35.9K 0.18% 76
2017
Q3 		$649K Sell
3,479
-250
-7% -$44.3K 0.19% 75
2017
Q2 		$642K Buy
3,729
+280
+8% +$45.5K 0.19% 74
2017
Q1 		$566K Sell
3,449
-255
-7% -$42.4K 0.18% 78
2016
Q4 		$542K Sell
3,704
-50
-1% -$7.53K 0.17% 76
2016
Q3 		$626K Sell
3,754
-600
-14% -$101K 0.21% 72
2016
Q2 		$662K Buy
+4,354
New +$677K 0.23% 71
2015
Q4 		$761K Buy
4,688
+2,085
+80% +$328K 0.28% 66
2015
Q3 		$400K Hold
2,603
– – 0.15% 88
2015
Q2 		$400K Buy
2,603
+190
+8% +$30.4K 0.15% 88
2015
Q1 		$386K Buy
2,413
+400
+20% +$63K 0.14% 89
2014
Q4 		$321K Buy
2,013
+580
+40% +$90.4K 0.12% 87
2014
Q3 		$201K Buy
+1,433
New +$187K 0.08% 110

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baxter Bros Inc's AMGN Position: Q1 2026 in Review

Baxter Bros Inc held its Amgen (AMGN) position steady in Q1 2026 at 2,081 shares worth $732K. The position accounts for 0.09% of the portfolio, ranked #101.

Baxter Bros Inc first reported a position in AMGN in Q3 2014 and has held it in 46 quarters since. The position peaked at $895K in Q4 2019. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Baxter Bros Inc held 2,081 shares of Amgen worth $732K as of Q1 2026.
  • Baxter Bros Inc left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.09% of Baxter Bros Inc's portfolio in Q1 2026, its #101 holding.
  • Baxter Bros Inc first reported a position in Amgen in Q3 2014 and has held it in 46 quarters since.
  • Baxter Bros Inc's Amgen position peaked at $895K in Q4 2019.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Baxter Bros Inc's 13F filing for Q1 2026, filed 28 Apr 2026.